Article Information
History
- October 27, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Asieh Golozar1,2,*,†;,
- Lana YH Lai3,*,
- Anthony G. Sena4,5,
- David Vizcaya6,
- Lisa M. Schilling7,
- Vojtech Huser8,
- Fredrik Nyberg9,
- Scott L. Duvall10,
- Daniel R. Morales11,
- Thamir M Alshammari12,
- Hamed Abedtash13,
- Waheed-Ul-Rahman Ahmed14,15,
- Osaid Alser16,
- Heba Alghoul17,
- Ying Zhang18,
- Mengchun Gong18,
- Yin Guan18,
- Carlos Areia19,
- Jitendra Jonnagaddala20,
- Karishma Shah14,
- Jennifer C.E. Lane14,
- Albert Prats-Uribe14,
- Jose D. Posada21,
- Nigam H. Shah21,
- Vignesh Subbian22,
- Lin Zhang23,24,
- Maria Tereza Fernandes Abrahão24,
- Peter R. Rijnbeek5,
- Seng Chan You26,
- Paula Casajust27,
- Elena Roel28,
- Martina Recalde28,29,
- Sergio Fernández-Bertolín28,
- Alan Andryc4,
- Jason A. Thomas30,
- Adam B. Wilcox30,31,
- Stephen Fortin32,
- Clair Blacketer4,5,
- Frank DeFalco4,
- Karthik Natarajan33,34,
- Thomas Falconer33,
- Matthew Spotnitz33,
- Anna Ostropolets33,
- George Hripcsak33,34,
- Marc Suchard35,
- Kristine E. Lynch10,
- Michael E. Matheny36,
- Andrew Williams37,
- Christian Reich38,
- Talita Duarte-Salles28,
- Kristin Kostka38,
- Patrick B. Ryan4,5 and
- Daniel Prieto-Alhambra39
- 1Regeneron Pharmaceutical, NY USA
- 2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD USA
- 3Division of Cancer Sciences, School of Medical Sciences, University of Manchester, UK
- 4Janssen R&D, Titusville NJ, USA
- 5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
- 6Bayer Pharmaceuticals, Sant Joan Despi, Spain
- 7Data Science to Patient Value Program, University of Colorado Anschutz Medical Campus
- 8National Library of Medicine, National Institutes of Health, Bethesda, MD, USA
- 9School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- 10VINCI, VA Salt Lake City Health Care System, Salt Lake City, VA, & Division of Epidemiology, University of Utah, Salt Lake City, UT
- 11Division of Population Health and Genomics, University of Dundee, UK
- 12Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia
- 13Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN
- 14Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
- 15College of Medicine and Health, University of Exeter, St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU, UK
- 16Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- 17Faculty of Medicine, Islamic University of Gaza, Palestine
- 18DHC Technologies Co. Ltd, Beijing, China
- 19Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
- 20School of Public Health and Community Medicine, UNSW Sydney, Australia
- 21Stanford University School of Medicine, Stanford, California, USA
- 22College of Engineering, The University of Arizona, Tucson, Arizona, USA
- 23School of Population Medicine and Public Health, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
- 24Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
- 25Faculty Medicine University of São Paulo, São Paulo, Brazil
- 26Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea
- 27Real-World Evidence, Trial Form Support, Barcelona, Spain
- 28Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
- 29Universitat Autònoma de Barcelona, Spain
- 30Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA
- 31UW Medicine, Seattle, WA, USA
- 32Observational Health Data Analytics, Janssen Research and Development, Raritan, NJ, USA
- 33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
- 34New York-Presbyterian Hospital, 622 W 168 St, PH20 New York, NY 10032 USA
- 35Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, USA
- 36VINCI, Tennessee Valley Healthcare System VA, Nashville, TN & Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN
- 37Tufts Institute for Clinical Research and Health Policy Studies, US
- 38Real World Solutions, IQVIA, Cambridge, MA, USA
- 39Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, UK
- ↵†Corresponding Author Asieh Golozar, Regeneron Pharmaceutical, NY USA, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD USA, Tel: +1(410)302-6641, email: asieh.golzoar{at}gmail.com
Posted October 27, 2020.
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States
